These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1342833)

  • 1. Competitive parabolic inhibition of bovine trypsin by bis-benzamidines.
    Junqueira RG; Silva E; Mares-Guia M
    Braz J Med Biol Res; 1992; 25(9):873-87. PubMed ID: 1342833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plausible identification of the secondary binding site in trypsin and trypsinogen.
    Andrade MH; Silva E; Mares-Guia M
    Braz J Med Biol Res; 1990; 23(12):1223-31. PubMed ID: 2136554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine 151 is part of the substrate activation binding site of bovine trypsin. Identification by covalent labeling with p-diazoniumbenzamidine and kinetic characterization of Tyr-151-(p-benzamidino)-azo-beta-trypsin.
    Oliveira MG; Rogana E; Rosa JC; Reinhold BB; Andrade MH; Greene LJ; Mares-Guia M
    J Biol Chem; 1993 Dec; 268(36):26893-903. PubMed ID: 8262923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural binding evidence of the trypanocidal drugs berenil and pentacarinate active principles to a serine protease model.
    Perilo CS; Pereira MT; Santoro MM; Nagem RA
    Int J Biol Macromol; 2010 Jun; 46(5):502-11. PubMed ID: 20356563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization of rat tissue kallikrein using N alpha-substituted arginine 4-nitroanilides and N alpha-benzoyl-L-arginine ethyl ester as substrates.
    Sousa MO; Rodrigues CV; Pena HB; Alvarenga MG; Machado-Coelho GL; Santoro MM; Juliano MA; Juliano L; Figueiredo AF
    Braz J Med Biol Res; 1996 Mar; 29(3):327-34. PubMed ID: 8736125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic evaluation and modeling of proton and water exchange associated with benzamidine and berenil binding to beta-trypsin.
    Pereira MT; Silva-Alves JM; Martins-José A; Lopes JC; Santoro MM
    Braz J Med Biol Res; 2005 Nov; 38(11):1593-601. PubMed ID: 16258627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
    Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
    J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors.
    Kam CM; Hernandez MA; Patil GS; Ueda T; Simmons WH; Braganza VJ; Powers JC
    Arch Biochem Biophys; 1995 Feb; 316(2):808-14. PubMed ID: 7864637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
    Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
    Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic mechanism of the inhibition of human urinary kallikrein by basic pancreatic trypsin inhibitor.
    Miranda TL; Ramos CH; Freire RT; Souza EP; Rogana E; Santoro MM; Figueiredo AF
    Braz J Med Biol Res; 1995 May; 28(5):505-12. PubMed ID: 8555969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of enzymes of polyamine back-conversion by pentamidine and berenil.
    Libby PR; Porter CW
    Biochem Pharmacol; 1992 Aug; 44(4):830-2. PubMed ID: 1510731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzamidine as a spectroscopic probe for the primary specificity subsite of trypsin-like serine proteinases. A case for BPTI binding to bovine beta-trypsin.
    Ascenzi P; Bolognesi M; Guarneri M; Menegatti E; Amiconi G
    Mol Cell Biochem; 1984 Sep; 64(2):139-44. PubMed ID: 6390168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
    Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
    J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substituent effect on complex formation between alpha-trypsin and para-substituted benzamidinium ions: a thermodynamic study.
    Rogana E; Penha-Silva N; Mares-Guia M
    Braz J Med Biol Res; 1989; 22(10):1177-90. PubMed ID: 2638191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration that 1-trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane (E-64) is one of the most effective low Mr inhibitors of trypsin-catalysed hydrolysis. Characterization by kinetic analysis and by energy minimization and molecular dynamics simulation of the E-64-beta-trypsin complex.
    Sreedharan SK; Verma C; Caves LS; Brocklehurst SM; Gharbia SE; Shah HN; Brocklehurst K
    Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):777-86. PubMed ID: 8670152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
    Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
    Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction between alpha-2 macroglobulin and trypsin with synthetic trypsin inhibitors].
    Krebs G
    Biochimie; 1979; 61(4):559-65. PubMed ID: 90529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.